Switzerland-based BioPartners has submitted a second Marketing
Authorisation Application in Europe for a generic copy of a
biologic drug under the recently agreed European Union framework
for so-called 'biosimilar' drugs.
Pharming of the Netherlands, which is pioneering the use of
transgenic animals for the production of biologics, has raised €6
million from a placing of shares and will use the proceeds to
advance its portfolio of clinical drug candidates.
Flint Ink North America has announced a price increase for
packaging ink products ranging from 5 to 7 per cent depending on
ink type. The increase, effective 1 December 2004, comes in
response to the rising costs of transportation,...
Research that could eventually lead to gene therapy treatment
options for patients with Parkinson's disease has been published
this week, which could bring hope to more than 1 million Americans
each year who suffer from this...
Scientists have identified a new, longer species of the amyloid
b-peptide that has the potential to be a new target for the
treatment of Alzheimer's disease The discovery serves as a basis
for treating one of the characteristic...
The UK Packaging and Industrial Films Association (PIFA) is warning
buyers of plastic film products to expect further price increases
as producers and converters are forced to look for recovery of
exceptional rising raw material costs....
Overcapacity remains the main issue affecting the European market
for active pharmaceutical ingredients, with lack of capability
differentiation and competition from low-cost manufacturers also
holding back growth in the sector.